Validation of plasma-derived small extracellular vesicles as cancer biomarkers
- PMID: 32943766
- DOI: 10.1038/s41571-020-00433-5
Validation of plasma-derived small extracellular vesicles as cancer biomarkers
Comment on
-
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.Cell. 2020 Aug 20;182(4):1044-1061.e18. doi: 10.1016/j.cell.2020.07.009. Epub 2020 Aug 13. Cell. 2020. PMID: 32795414 Free PMC article.
References
-
- Theodoraki, M. N. et al. Significance of PD-L1( + ) exosomes in plasma of head and neck cancer patients. Clin. Cancer Res. 24, 896–905 (2018). - DOI
-
- Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560, 382–386 (2018). - DOI
-
- Theodoraki, M. N. et al. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology 8, 1593805 (2019). - DOI
-
- Whiteside, T. L. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update. Expert Rev. Mol. Diagn. 18, 1029–1040 (2018). - DOI
-
- Kalluri R. The biology and function of exosomes in cancer. J. Clin. Invest. 126, 1208–1215
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
